4 Once a diagnosis of primary hyperhidrosis has been determined, treatment is initiated to help control the sweating and increase the patient’s quality of life (QOL). In the United States ...

Treatment of hyperhidrosis can be divided into topical, oral, surgical, and nonsurgical treatments (botulinum toxin). These therapeutic options differ with respect to their efficacy, duration of ...

Medically reviewed by Sarah Richards, DPM The feet have more sweat glands per inch than any other body part, producing sweat ...

Searching for effective treatment options for 'Hyperhidrosis symptom'? This page is a valuable resource, featuring a complete guide to the latest medications-both generic and branded-ideal for ...

If you experience excessive sweating and are taking any of these medications, speak with a healthcare professional. They could help review your treatment plan. The most common symptom of ...

Anxiety-induced hyperhidrosis can feel overwhelming. Understanding the connection between anxiety and sweating, practicing ...

Medically reviewed by Leah Ansell, MD Fact checked by Sarah Scott Hyperhidrosis is a term used to describe excessive sweating ...

Botox injections have been FDA approved to treat excessive sweating. In the skin, Botox selectively turns off the sweat glands resulting in a normal appearance without wetness. Treatment is performed ...

One of the most recent treatments is an injection of botulinum toxin (Botox®) into the area of excessive sweating. Botulinum is a toxin that affects nerve endings and decreases the transmission of the ...

Sofpironium bromide in the treatment of primary axillary hyperhidrosis improves Hyperhidrosis Disease Severity Scale scores, reduces gravimetric weight of sweat, and improves Dermatology Life ...

Introduction: Axillary hyperhidrosis can be a source of social isolation and embarrassment. The available treatments are either ineffective or have intolerable side effects. The search for a ...

(Nasdaq: NASDAQ:RVNC), two biotechnology firms, have announced a collaboration to start a Phase 2a clinical trial for a novel treatment of primary axillary hyperhidrosis, commonly known as ...